HCM
LLY icon

Highfields Capital Management’s Eli Lilly LLY Stock Holding History

Highfields Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-550,000
Closed -$40M – 83
2015
Q1 		$40M Hold
550,000
– – 0.36% 40
2014
Q4 		$37.9M Sell
550,000
-105,100
-16% -$7.09M 0.32% 46
2014
Q3 		$42.5M Hold
655,100
– – 0.33% 54
2014
Q2 		$40.7M Buy
+655,100
New +$39.1M 0.3% 60

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Highfields Capital Management's LLY Position: Q4 2018 in Review

Highfields Capital Management sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 350,000 shares — an estimated $37.6M sold.

Highfields Capital Management first reported a position in LLY in Q2 2014 and held it in 7 quarters. The position peaked at $249M in Q2 2014. 1,561 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • Highfields Capital Management reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
  • Highfields Capital Management sold 350,000 Eli Lilly shares in Q4 2018, an estimated $37.6M.
  • Highfields Capital Management first reported a position in Eli Lilly in Q2 2014 and held it in 7 quarters.
  • Highfields Capital Management's Eli Lilly position peaked at $249M in Q2 2014.
  • 1,561 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Highfields Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.